SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+11.17%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$900M
AUM Growth
+$900M
(+11%)
Cap. Flow
-$78M
Cap. Flow
% of AUM
-8.67%
Top 10 Holdings %
Top 10 Hldgs %
42.92%
Holding
115
New
38
Increased
26
Reduced
29
Closed
13
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$32M |
| 2 |
United Therapeutics
UTHR
|
$23.5M |
| 3 |
Humana
HUM
|
$17.4M |
| 4 |
Surmodics
SRDX
|
$13.9M |
| 5 |
The Beauty Health Co
SKIN
|
$11.6M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$51.8M |
| 2 |
Exact Sciences
EXAS
|
$36.3M |
| 3 |
Smith & Nephew
SNN
|
$15.5M |
| 4 |
SI-BONE Inc
SIBN
|
$11.7M |
| 5 |
Vericel Corp
VCEL
|
$9.75M |
Sector Composition
| 1 | Healthcare | 96.82% |
| 2 | Consumer Staples | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Syndax Pharmaceuticals
SNDX
$1.39B
| $4.45M | 0.49% |
212,600
-110,000
| -34% | -$2.3M |
|
52
89bio
ETNB
$1.37B
| $4.29M | 0.48% |
226,500
-267,500
| -54% | -$5.07M |
|
53
DexCom
DXCM
$30.9B
| $4.24M | 0.47% |
+33,000
| New | +$4.24M |
|
54
GeneDx Holdings
WGS
$3.65B
| $4.24M | 0.47% |
711,396
+167,760
| +31% | +$1,000K |
|
|
CBAY
55
DELISTED
Cymabay Therapeutics
CBAY
| $4.08M | 0.45% |
+373,000
| New | +$4.08M |
|
56
4D Molecular Therapeutics
FDMT
$302M
| $3.96M | 0.44% |
219,148
-250,252
| -53% | -$4.52M |
|
57
Verastem
VSTM
$585M
| $3.87M | 0.43% |
+520,369
| New | +$3.87M |
|
|
DICE
58
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $3.72M | 0.41% |
80,000
-93,447
| -54% | -$4.34M |
|
59
InspireMD
NSPR
$101M
| $3.46M | 0.38% |
+1,378,128
| New | +$3.46M |
|
60
Immunovant
IMVT
$2.91B
| $3.29M | 0.37% |
+173,599
| New | +$3.29M |
|
61
Twist Bioscience
TWST
$1.57B
| $3.27M | 0.36% |
+160,000
| New | +$3.27M |
|
|
KRTX
62
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.07M | 0.34% |
14,140
-19,600
| -58% | -$4.25M |
|
63
Keros Therapeutics
KROS
$640M
| $2.84M | 0.32% |
70,800
-51,516
| -42% | -$2.07M |
|
64
Amylyx Pharmaceuticals
AMLX
$877M
| $2.59M | 0.29% |
120,000
+56,786
| +90% | +$1.22M |
|
65
Xenon Pharmaceuticals
XENE
$2.99B
| $2.54M | 0.28% |
+66,000
| New | +$2.54M |
|
66
Galecto
GLTO
$3.93M
| $2.52M | 0.28% |
+40,000
| New | +$2.52M |
|
|
67
Vericel Corp
VCEL
$1.69B
| $2.52M | 0.28% |
67,049
-259,400
| -79% | -$9.75M |
|
68
Lyra Therapeutics
LYRA
$11.8M
| $2.43M | 0.27% |
11,848
| – | – |
|
69
Praxis Precision Medicines
PRAX
$980M
| $2.42M | 0.27% |
+140,000
| New | +$2.42M |
|
70
CRISPR Therapeutics
CRSP
$4.82B
| $2.38M | 0.26% |
+42,400
| New | +$2.38M |
|
|
WHWK
71
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $2.28M | 0.25% |
+333,227
| New | +$2.28M |
|
72
Black Diamond Therapeutics
BDTX
$164M
| $2.2M | 0.24% |
+435,000
| New | +$2.2M |
|
73
Annexon
ANNX
$225M
| $2.18M | 0.24% |
620,400
-295,000
| -32% | -$1.04M |
|
74
Inspire Medical Systems
INSP
$2.53B
| $2.18M | 0.24% |
6,700
-8,900
| -57% | -$2.89M |
|
75
Eli Lilly
LLY
$661B
| $2.02M | 0.22% |
+4,300
| New | +$2.02M |
|